- Home
- LESL vs CELU Comparison
LESL vs CELU Comparison
Compare LESL & CELU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LESL
- CELU
- Stock Information
- Founded
- LESL 1963
- CELU 2016
- Country
- LESL United States
- CELU United States
- Employees
- LESL N/A
- CELU N/A
- Industry
- LESL Diversified Commercial Services
- CELU Biotechnology: Pharmaceutical Preparations
- Sector
- LESL Miscellaneous
- CELU Health Care
- Exchange
- LESL Nasdaq
- CELU Nasdaq
- Market Cap
- LESL 66.9M
- CELU 64.3M
- IPO Year
- LESL 2020
- CELU N/A
- Fundamental
- Price
- LESL $4.75
- CELU $2.05
- Analyst Decision
- LESL Hold
- CELU Strong Buy
- Analyst Count
- LESL 9
- CELU 1
- Target Price
- LESL $33.25
- CELU $6.00
- AVG Volume (30 Days)
- LESL 193.8K
- CELU 165.3K
- Earning Date
- LESL 11-24-2025
- CELU 08-29-2025
- Dividend Yield
- LESL N/A
- CELU N/A
- EPS Growth
- LESL N/A
- CELU N/A
- EPS
- LESL N/A
- CELU N/A
- Revenue
- LESL $1,250,568,000.00
- CELU $44,590,000.00
- Revenue This Year
- LESL N/A
- CELU N/A
- Revenue Next Year
- LESL $0.64
- CELU $76.00
- P/E Ratio
- LESL N/A
- CELU N/A
- Revenue Growth
- LESL N/A
- CELU 4.45
- 52 Week Low
- LESL $4.31
- CELU $1.00
- 52 Week High
- LESL $72.60
- CELU $5.22
- Technical
- Relative Strength Index (RSI)
- LESL 68.45
- CELU 38.22
- Support Level
- LESL $5.43
- CELU $2.00
- Resistance Level
- LESL $6.92
- CELU $2.20
- Average True Range (ATR)
- LESL 0.44
- CELU 0.17
- MACD
- LESL 0.37
- CELU 0.03
- Stochastic Oscillator
- LESL 67.52
- CELU 15.33
About LESL Leslie's Inc.
Leslies Inc is a direct-to-consumer pool and spa care brand offering a comprehensive assortment of products across chemicals, equipment and parts, cleaning and maintenance equipment, and safety, recreational, and fitness-related products. The company offers its products and services for Residential Pool, Residential Spa, Professional Pool, and Commercial Pool consumers. Geographically, it operates only in the United States.
About CELU Celularity Inc.
Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.